Switching to High-Dose Aflibercept (8 mg) with Pro Re Nata Reduces Treatment Burden in Diabetic Macular Edema: A Real-World Pilot Study.
Saved in:
| Title: | Switching to High-Dose Aflibercept (8 mg) with Pro Re Nata Reduces Treatment Burden in Diabetic Macular Edema: A Real-World Pilot Study. |
|---|---|
| Authors: | Funatsu, Masahiko1 (AUTHOR), Higashijima, Fumiaki1,2 (AUTHOR), Ariyoshi, Nobuaki1 (AUTHOR), Haraguchi, Aiko1,2 (AUTHOR), Wasai, Yuki1 (AUTHOR), Mikuni, Masanori1 (AUTHOR), Ohta, Manami1 (AUTHOR), Wakuta, Makiko1 (AUTHOR), Hirano, Shinji1 (AUTHOR), Yamauchi, Kazuhiko2 (AUTHOR), Kimura, Kazuhiro1 (AUTHOR) k.kimura@yamaguchi-u.ac.jp |
| Source: | Journal of Clinical Medicine. Mar2026, Vol. 15 Issue 6, p2210. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
